Hayfin Capital Management LLP

Hayfin’s Mirja Lehmler-Brown recently featured in FundFire to discuss the popularity and performance of continuation funds. Highlighting how continuation vehicles have evolved to support investors with high-quality assets, Mirja demonstrates that these structures can help to unlock additional value in private equity portfolios and why she anticipates a steady trajectory for this market.   Read more here: https://lnkd.in/eHXVJ-qF   #Hayfin #PrivateEquitySolutions #AlternativeInvestments

A huge thank you to our clients and colleagues who joined us at The Londoner last week for our Annual Investor Day. Set against the iconic backdrop of Leicester Square, we welcomed attendees from across the world to celebrate and reflect on Hayfin’s achievements over the past year. Our investment teams from private credit, liquid credit, and private equity took centre stage, delivering a comprehensive update on each strategy. The event reinforced that we’re not just moving forward, but actively accelerating in our commitment to providing best-in-class service to the partners who have entrusted us with their time and capital since Hayfin’s inception 15 years ago. We would also like to extend a special thank you to our guest panellists Manuel Martínez-Fidalgo, Rikesh Patel, Pat Gunne and Dr Cath Bishop for her inspiring discussion on resilience. Finally, a huge thank you to all our team who made this event a great success. #InvestorDay

Greater transparency is an ongoing trend within private markets. In an environment of increased regulatory scrutiny on asset valuations, Hayfin’s Michaela Campbell recently discussed the use cases of AI to enhance investment processes with Nick Fitzpatrick. As more traditional investors enter the private markets, Michaela's timely insights are available to read in the Funds Europe 'Investment Data in Private Markets' report.   You can read the full report here: https://lnkd.in/e6zrRQwh #privatecredit

We are pleased to announce that we are acting as co-lead investor, alongside funds managed by Morgan Stanley Private Equity Secondaries, in a €320 million Single-Asset Continuation Fund established by Impilo to support the next phase of ownership of Immedica Pharma AB.   Headquartered in Stockholm, Sweden, Immedica is a pharmaceutical company focused on the commericalisation of specialty medicines for rare and orphan diseases. Serving patients in more than 50 countries, Immedica is fully dedicated to helping those living with diseases which have a large unmet medical need.   Read more: https://lnkd.in/exksDb_b

I’m excited to be joining Private Equity Insights ‘Secondaries: GP vs. LP-Leds’ panel discussion. If you’re attending, please do reach out!

Hayfin’s Mark Bickerstaffe and Rob Kneip attended the PICTON Latam 2024 Summit. Mark joined the Direct Lending panel to discuss some of the critical issues affecting the private credit industry including the nuances between European and US markets, the growth of club deals and why borrowers are continuing to favour private credit over syndicated loans. Read Hayfin’s views on these themes in our recent Why Europe report, which highlights the unique opportunities offered by the European private credit market, here: https://lnkd.in/deszajqS #DirectLending #PrivateCredit

We were thrilled to host another successful Golf Day last Friday at Clandon Regis Golf Club, organised and sponsored by Hayfin Capital and Greenheart Management. 17 teams from the maritime industry competed, raising an incredible £20,000 for seafarer wellbeing services. These donations will be used to continue to support seafarer welfare, advocacy, mental health, and family support. Our Director of Finance, Eileen Reilly, delivered a speech highlighting the vital work of the Mission in supporting seafarers and why their generosity can make a life-changing difference. We thank Brian Nixon and Jeremy Dean for organising this event on our behalf and everyone involved in raising funds for seafarers’ welfare. Thank you all for your contributions! Companies represented include Hayfin Capital Management LLP, Reed Smith LLP, Watson Farley , Affinity LLP, Clarksons, Carisbrooke Shipping Ltd, Hartland Shipping Services Limited, Baltic Exchange, Braemar, Island View Shipping, Bermuda Shipping & Maritime, Hill Dickinson LLP, Arrow Shipping and Bankserve.

At Hayfin, we are committed to helping cutting edge healthcare businesses fulfil their potential. That is why we're proud to have supported Allergy Therapeutics, a leader in British pharmaceutical innovation for allergy treatments, in continuing to grow their R&D and commercial success.

We are looking forward to Steve Bringardner, CFA's appearance at this year's Coalition Greenwich (a division of CRISIL) Competitive Challenges Conference. Alongside KKR's Kate B. and HarbourVest Partners's James Kase, Steve will join the panel to discuss distribution effectiveness in a maturing private marketplace.

Looking forward to joining the 'Operational infrastructure and portfolio monitoring' panel on Wednesday alongside Edward Smalley, Mei-Li da Silva Vint, Joss Trout and Jonathan White. If you’re attending, please do say hello!